ASCOR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ascor, and what generic alternatives are available?
Ascor is a drug marketed by Mcguff and is included in one NDA.
The generic ingredient in ASCOR is ascorbic acid. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ascorbic acid profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ASCOR?
- What are the global sales for ASCOR?
- What is Average Wholesale Price for ASCOR?
Summary for ASCOR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 171 |
| Patent Applications: | 3,476 |
| Drug Prices: | Drug price information for ASCOR |
| What excipients (inactive ingredients) are in ASCOR? | ASCOR excipients list |
| DailyMed Link: | ASCOR at DailyMed |
Pharmacology for ASCOR
| Drug Class | Vitamin C |
US Patents and Regulatory Information for ASCOR
ASCOR is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting ASCOR
FOR TREATMENT OF SCURVY IN ADULT AND PEDIATRIC PATIENTS AGE 5 MONTHS AND OLDER FOR WHOM ORAL ADMINISTRATION IS NOT POSSIBLE, INSUFFICIENT OR CONTRAINDICATED
Exclusivity Expiration: ⤷ Sign Up
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mcguff | ASCOR | ascorbic acid | SOLUTION;INTRAVENOUS | 209112-001 | Oct 2, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
